TOKYO, Oct 16, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that amyotrophic lateral sclerosis (ALS) treatment "Rozebalamin(R) for Injection 25 mg" (mecobalamin) has received the Good ...
Learn about Amyotrophic Lateral Sclerosis (ALS), its symptoms, risk factors, diagnosis, and current research advancements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback